Rossi; Derrick J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rossi; Derrick J..The latest application filed is for "compositions and methods for non-myeloablative conditioning".

Company Profile

11.9.21

Rossi; Derrick J. - Newton MA
ROSSI; Derrick J. - Boston MA
Rossi; Derrick J. - Roslindale MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Non-myeloablative Conditioning App 20210388094 - Scadden; David T. ; et al.	2021-12-16
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20210285015 - Musunuru; Kiran ; et al.	2021-09-16
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20210277423 - Musunuru; Kiran ; et al.	2021-09-09
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20210274726 - Musunuru; Kiran ; et al.	2021-09-09
Compositions and methods for non-myeloablative conditioning Grant 10,906,980 - Scadden , et al. February 2, 2	2021-02-02
Methods And Compositions Relating To Hematopoietic Stem Cell Expansion, Enrichment, And Maintenance App 20200248143 - Kind Code	2020-08-06
Antibody-mediated Conditioning With Immunosuppression To Enable Allogeneic Transplantation App 20200188527 - ROSSI; Derrick J. ; et al.	2020-06-18
Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance Grant 10,669,528 - Rossi , et al.	2020-06-02
Methods And Compositions Relating To Homology-directed Repair App 20200149038 - ROSSI; Derrick J. ; et al.	2020-05-14
Compositions And Methods For Non-myeloablative Conditioning App 20200148776 - Scadden; David T. ; et al.	2020-05-14
Compositions and methods for non-myeloablative conditioning Grant 10,570,207 - Scadden , et al. Feb	2020-02-25
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20200048659 - Musunuru; Kiran ; et al.	2020-02-13
Efficient Protein Expression In Vivo Using Modified Rna (mod-rna) App 20200000881 - Chien; Kenneth R. ; et al.	2020-01-02
Compositions and methods for non-myeloablative conditioning Grant 10,280,225 - Scadden , et al.	2019-05-07
Methods And Compositions Relating To Hematopoietic Stem Cell Expansion App 20190119642 - ROSSI; Derrick J. ; et al.	2019-04-25
Efficient Protein Expression In Vivo Using Modified Rna (mod-rna) App 20190117733 - Chien; Kenneth R. ; et al.	2019-04-25
Compositions And Methods For Non-myeloablative Conditioning App 20190100593 - Scadden; David T. ; et al.	2019-04-04
Therapeutic uses of genome editing with CRISPR/Cas systems Grant 10,208,319 - Musunuru , et al. Feb	2019-02-19
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20180291383 - Musunuru; Kiran ; et al.	2018-10-11
Efficient protein expression in vivo using modified RNA (MOD-RNA) Grant 10,086,043 - Chien , et al. October 2, 2	2018-10-02
Hematopoietic stem cell specific reporter mouse and uses thereof Grant 10,080,354 - Rossi , et al. September 25, 2	2018-09-25
Methods And Compositions Relating To Hematopoietic Stem Cell Expansion, Enrichment, And Maintenance App 20180187156 - ROSSI; Derrick J. ; et al.	2018-07-05
Method of making a deletion in a target sequence in isolated primary cells using Cas9 and two guide RNAs Grant 9,822,370 - Musunuru , et al. November 21, 2	2017-11-21
Hematopoietic Stem Cell Specific Reporter Mouse And Uses Thereof App 20150223436 - Rossi; Derrick J. ; et al.	2015-08-13
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20150176013 - Musunuru; Kiran ; et al.	2015-06-25
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20150152436 - Musunuru; Kiran ; et al.	2015-06-04
THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS App 20150071889 - Musunuru; Kiran ; et al.	2015-03-12
Efficient Protein Expression In Vivo Using Modified Rna (mod-rna) App 20140073687 - Chien; Kenneth R. ; et al.	2014-03-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.